Home
Log In
Reset your password

Rozlytrek®: Leading a new era in oncology

A virtual symposium on advances in personalised healthcare for management of patients with ROS1+ NSCLC and NTRK fusion+ solid tumours

Date of preparation: September 2020

M-XX-00002762 / Approval code

logoRoche Logo

chatbox

This medical product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 of the SmPC for details on how to report adverse reactions.